In light of the fact that nuclear SMAD2/SMAD3/SMAD4 expression was significantly associated with ccRCC prognosis [22], SMAD proteins may be targets of pAMPK in regulating the behavior of ccRCC. The gene discussed is SMAD3; the disease is nonpapillary renal cell carcinoma.